[April 27, 2015] |
|
First FDA Cleared Ophthalmic App for Monitoring AMD and DR
Vital
Art and Science, LLC (VAS), an emerging ophthalmic medical device
company, has introduced the mVT™ Service, an innovative medical device
and physician portal that conveniently and accurately tracks the
progression of vision damaging diseases such as age related macular
degeneration and diabetic retinopathy. The device is available only by
prescription and consists of an easily downloaded app that can be used
on any Apple (News - Alert) smartphone or tablet. Patient test data are automatically
uploaded to a Physician's Portal where licensed eye-care professionals
can monitor all patient test results.
Age related macular degeneration is the leading cause of blindness for
people over 60, and diabetic retinopathy vision loss continues to grow
with the increasing prevalence of diabetes. The new
mVT™ Service is the only simple, low cost, mobile, validated method
available for these patients to test their vision at home. Patients take
a simple 4-6 minute self-test, performed on the timetable recomended by
the doctor (usually twice a week). The patient's confidential results
are automatically delivered to the Physician Portal for review and
analysis.
The mVT™ Service utilizes proven patented proprietary algorithms to
assess visual function and detect changes between physician visits. A
significant change in the eye condition sends an alert to the doctor who
will determine if an earlier intervention is required, such as new
appointment, assessment or treatment.
"Our clinical trials have confirmed that the results from this
convenient home test correlate well with in-office physician assessment
and can potentially improve clinical outcomes by bringing in patients
for earlier-than-planned examination and possibly treatment," stated Mike
Bartlett, company president. Studies have shown that catching and
treating vision degradation early may prevent some vision loss.
"Compliance with the prescribed mVT™ use is very high and patients feel
more engaged in the management of their disease. Both patients and
doctors appreciate the convenience," Bartlett added. "Patients like to
test at home and doctors like having the results automatically collected
and available anytime for analysis," he added.
The mVT™ Service, which includes the App and the Physician's Portal, is
available by prescription only and costs patients $8.95/month.
VAS is currently reviewing strategic partnerships and other
opportunities with the mVT™ Service.
VAS is also welcoming a limited number of qualified prescribers into its
early release program, the goal of which is to obtain prescriber/patient
feedback and assure the mVT™ Service meets their needs.
Vital
Art and Science, LLC, is advancing and commercializing innovative
home diagnostics for treatable chronic diseases. VAS's strategy has been
to leverage the unique strengths of the Dallas/Fort Worth area
universities and research facilities, as well as local electronic,
telecommunications and health care companies. VAS is located at 17217
Waterview Pkwy, Richardson (News - Alert), TX 75252, 1-844-267-8019. For more
information visit www.myvisiontrack.com.
[ Back To Mobile World Congress's Homepage ]
|